Stay updated on Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial

Sign up to get notified when there's something new on the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The study record history now includes revision v3.3.2 and removes v3.3.1, updating the version history without changing core trial data.
    Difference
    0.1%
    Check dated 2025-11-30T06:16:32.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The Record History now includes a new revision entry (v3.3.1) and removes the previous revision (v3.2.0), a change limited to the audit trail and not affecting study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-23T07:51:14.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    A government funding notice about potential delays and operating status has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2025-11-16T05:49:01.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The history page shows newer version entries and metadata updates, while the core study details remain unchanged.
    Difference
    0.1%
    Check dated 2025-11-01T23:53:48.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Difference
    12%
    Check dated 2025-10-04T02:52:16.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Page update: new date and study identifiers added (v3.1.0), replacing older date and revision (v3.0.2).
    Difference
    2%
    Check dated 2025-09-27T02:08:11.000Z thumbnail image

Stay in the know with updates to Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page.